Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
11/24/2022
Drug R&D and Approvals in China – October Update on YouTube (PharmCub...
11/23/2022
Shanghai Issues the "Certain Policy Measures to Accelerate Building of...
11/23/2022
Fibrogen Sues Andao / Kind Pharma and Two Ex-employees for Stolen Pate...
11/23/2022
Jinyao Pharma Fined CNY 27.72M for Additional Monopoly Violation
11/23/2022
WuXi AppTec Begins Construction of Wuxi STA's East China R&D Facility
11/23/2022
GlobalData: Chinese Manufacturers' Transition to Innovative Pharma Req...
11/23/2022
China to Cut Tax for More Anticancer and Rare Disease Drugs
11/23/2022
NMPA and Chinese Customs Announce Addition of Shijiazhuang Airport as ...
11/23/2022
Hainan Issues New Policy to Improve Drug Import Process
11/23/2022
Nona Biosciences Enters into HCAb Based Drug Discovery Partnership wit...
11/23/2022
Umoja Biopharma and IASO Biotherapeutics Enter Partership for Off-the-...
11/22/2022
Measures for Supervision and Administration of Online Sales of Drugs: ...
11/22/2022
Legal Considerations for International Licensors and Licensees Conduct...
11/21/2022
Biotech CEO Interview: Harbour BioMed's Wang On Moderna Deal, New Subs...
11/21/2022
Performance of A Share-listed MedPharm Cos Improved in Q3/2022
11/21/2022
CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...
11/21/2022
CDE Solicits Comments on the Technical Guidelines for Clinical Protoco...
11/21/2022
CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...
11/18/2022
CDE, Hainan Provincial Drug Admin Jointly Issue the Implementation Rul...
11/18/2022
Recent Executive Moves
11/18/2022
Drug R&D and Product Registration News Digest November 2022 (3)
11/17/2022
CDE Solicits Comments on the Technical Guidelines for Clinical Researc...
11/17/2022
Mirati Therapeutics Sues China's InventisBio for CNY 99M in Trade Sec...
11/17/2022
Marinus Pharma and Tenacia Biotech Tie Up for Ganaxolone Development ...
11/17/2022
IPF Presents Big Opportunities and Challenges for China Drugmakers
11/17/2022
Growing Pains: Charting The Rapid Rise Of Chinese IO (In Vivo - Pharma...
11/16/2022
Kinarus Therapeutics Engages Great Health Companion Group to Explore P...
11/16/2022
CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...
11/16/2022
CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...
11/16/2022
NHC Reorganizes Medical Administration Departments to Emphasize Epidem...
Page:
144
/
798
Total number of articles:
23924
:
[First]
[<<]
[142]
[143]
[144]
[145]
[146]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit